Humana Inc. (NYSE:HUM)‘s stock had its “equal weight” rating reiterated by Barclays PLC in a report released on Friday. They currently have a $191.00 target price on the insurance provider’s stock. Barclays PLC’s target price would suggest a potential upside of 12.43% from the stock’s current price.
A number of other analysts have also recently commented on HUM. Leerink Swann reissued an “outperform” rating on shares of Humana in a research report on Tuesday, June 21st. Wolfe Research assumed coverage on Humana in a research report on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 price target on the stock. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. JPMorgan Chase & Co. cut Humana from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $196.00 to $150.00 in a research report on Friday, July 8th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating on shares of Humana in a research report on Saturday, July 9th. Seven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Humana has an average rating of “Buy” and a consensus price target of $200.50.
Shares of Humana (NYSE:HUM) opened at 169.89 on Friday. The stock has a market capitalization of $25.32 billion, a P/E ratio of 26.10 and a beta of 0.90. Humana has a 52-week low of $150.00 and a 52-week high of $191.65. The firm has a 50-day moving average price of $175.73 and a 200-day moving average price of $175.51.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. Humana had a return on equity of 11.11% and a net margin of 1.76%. The firm had revenue of $14 billion for the quarter, compared to analysts’ expectations of $13.59 billion. During the same period in the previous year, the firm posted $1.67 EPS. The business’s revenue for the quarter was up 2.0% compared to the same quarter last year. On average, analysts predict that Humana will post $9.24 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Tuesday, October 11th. Humana’s dividend payout ratio (DPR) is presently 18.18%.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Point72 Asia Hong Kong Ltd bought a new position in Humana during the second quarter valued at approximately $126,000. Daiwa SB Investments Ltd. increased its position in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares during the period. Bessemer Group Inc. increased its position in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares during the period. Fulton Bank N.A. bought a new position in Humana during the third quarter valued at approximately $229,000. Finally, BB&T Securities LLC increased its position in Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock valued at $247,000 after buying an additional 165 shares during the period. 93.27% of the stock is owned by institutional investors and hedge funds.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.